AAAAAA

   
Results: 1-10 |
Results: 10
Subchronic exposure of [H-3]-2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) infemale B6C3F1 mice: Relationship of steady-state levels to disposition andmetabolism
Authors: Diliberto, JJ DeVito, MJ Ross, GD Birnbaum, LS
Citation: Jj. Diliberto et al., Subchronic exposure of [H-3]-2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) infemale B6C3F1 mice: Relationship of steady-state levels to disposition andmetabolism, TOXICOL SCI, 61(2), 2001, pp. 241-255
Regulation of the adhesion versus cytotoxic functions of the Mac-1/CR3/alpha(M)beta(2)-integrin glycoprotein
Authors: Ross, GD
Citation: Gd. Ross, Regulation of the adhesion versus cytotoxic functions of the Mac-1/CR3/alpha(M)beta(2)-integrin glycoprotein, CR R IMMUN, 20(3), 2000, pp. 197
Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan
Authors: Yan, J Vetvicka, V Xia, Y Hanikyrova, M Mayadas, TN Ross, GD
Citation: J. Yan et al., Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan, IMMUNOPHARM, 46(1), 2000, pp. 39-54
Roles of integrins CR3 and CR4 in disease and therapeutic strategies
Authors: Xia, Y Ross, GD
Citation: Y. Xia et Gd. Ross, Roles of integrins CR3 and CR4 in disease and therapeutic strategies, CONT IMMUN, 9, 2000, pp. 171-204
Therapeutic intervention with complement and beta-glucan in cancer
Authors: Ross, GD Vetvicka, V Yan, J Xia, Y Vetvickova, J
Citation: Gd. Ross et al., Therapeutic intervention with complement and beta-glucan in cancer, IMMUNOPHARM, 42(1-3), 1999, pp. 61-74
beta-glucan, a "Specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptortype 3 (CD11b/CD18)
Authors: Yan, J Vetvicka, V Xia, Y Coxon, A Carroll, MC Mayadas, TN Ross, GD
Citation: J. Yan et al., beta-glucan, a "Specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptortype 3 (CD11b/CD18), J IMMUNOL, 163(6), 1999, pp. 3045-3052
The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells
Authors: Xia, Y Vetvicka, V Yan, J Hanikyrova, M Mayadas, T Ross, GD
Citation: Y. Xia et al., The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells, J IMMUNOL, 162(4), 1999, pp. 2281-2290
Generation of recombinant fragments of CD11b expressing the functional beta-glucan-binding lectin site of CR3 (CD11b/CD18)
Authors: Xia, Y Ross, GD
Citation: Y. Xia et Gd. Ross, Generation of recombinant fragments of CD11b expressing the functional beta-glucan-binding lectin site of CR3 (CD11b/CD18), J IMMUNOL, 162(12), 1999, pp. 7285-7293
Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules
Authors: Vetvicka, V Hanikyrova, M Vetvickova, J Ross, GD
Citation: V. Vetvicka et al., Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules, CLIN EXP IM, 115(2), 1999, pp. 229-235
A mixed population of immature and mature leucocytes in umbilical cord blood results in a reduced expression and function of CR3 (CD11b/CD18)
Authors: Reddy, RK Xia, Y Hanikyrova, M Ross, GD
Citation: Rk. Reddy et al., A mixed population of immature and mature leucocytes in umbilical cord blood results in a reduced expression and function of CR3 (CD11b/CD18), CLIN EXP IM, 114(3), 1998, pp. 462-467
Risultati: 1-10 |